Author: Brittney Wheeler

Washington University in St. Louis’ Emergency Management Department has been awarded full accreditation by the Emergency Management Accreditation Program, an accomplishment only eight universities in the country have achieved.

People with Down syndrome nearly always develop signs of Alzheimer’s as they age. School of Medicine researchers are taking part in a multisite study to understand how Alzheimer’s develops in this population, with a long-term goal of finding ways to prevent or treat the disease.

An international team of researchers led by scientists at the School of Medicine has identified two regions in our DNA — one newly identified and a second that replicates a past finding — that appear to contribute to one’s risk of becoming dependent on marijuana.

Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine to speed the development of treatments for multiple neurodegenerative conditions.

A new, international phase 3 clinical trial led by the Washington University School of Medicine and funded by the National Institutes of Health (NIH), will investigate the potential of three drugs to tame a dangerous inflammatory response seen in some COVID-19 patients.

School of Medicine researchers have received an $8.5 million grant to study the role of gut viruses in inflammatory bowel disease. Tools developed in the course of the project could accelerate research into other roles of the virome in health and disease.

A new grant for research at the School of Medicine focuses on brain scans and other markers of Alzheimer’s. The aim is to establish whether early markers of disease in white populations also apply to African Americans.

New research — co-led by Washington University School of Medicine — has identified the most important features of cancer cells’ protein fragments, which can help distinguish the tumor from healthy tissue, enabling researchers to design better immunotherapies, including vaccines.

The university’s crisis response fund will continue to support employees affected by the COVID-19 crisis. Applications for assistance open Monday, Oct. 12, and will remain open through Oct. 30. The fund already has distributed support to student applicants this fall.

The Washington University in St. Louis community is invited to gather together virtually at noon Thursday, Oct. 8, for “Reflections: Remember & Recommit,” an event that will provide a space for grief and hope during this extraordinary time.